IS5239A - Notkun á hliðstæðum gamma-amínósmjörsýru (GABA) áborð við GABA-pentín til vinnslu lyfs til meðferðar á bólgusjúkdómum - Google Patents

Notkun á hliðstæðum gamma-amínósmjörsýru (GABA) áborð við GABA-pentín til vinnslu lyfs til meðferðar á bólgusjúkdómum

Info

Publication number: IS5239A
Authority: IS; Iceland
Prior art keywords: gaba; pentin; analogous; tablets; gamma
Prior art date: 1997-06-25

Application number

IS5239A

Other languages

English (en)

Other versions

IS2279B (is

Inventor

Schrier Denis

Price Taylor Charles Jr.

Nanette Westlund-High Karin

Original Assignee

Warner-Lambert Company

Board Of Regents Of The University Of Texas System

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-25

Filing date

1999-11-05

Publication date

1999-11-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26728613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS5239(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-05 Application filed by Warner-Lambert Company, Board Of Regents Of The University Of Texas System filed Critical Warner-Lambert Company

1999-11-05 Publication of IS5239A publication Critical patent/IS5239A/is

2007-09-15 Publication of IS2279B publication Critical patent/IS2279B/is

Links

BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title abstract 5
UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title abstract 4
229960002870 gabapentin Drugs 0.000 title abstract 2
208000027866 inflammatory disease Diseases 0.000 title abstract 2
OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 title 2
229960003692 gamma aminobutyric acid Drugs 0.000 title 2
229960001233 pregabalin Drugs 0.000 abstract 1
AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IS5239A 1997-06-25 1999-11-05 Notkun á hliðstæðum gamma-amínósmjörsýru (GABA) áborð við GABA-pentín til vinnslu lyfs til meðferðar á bólgusjúkdómum IS2279B (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US5073697P	1997-06-25	1997-06-25
US8418398P	1998-05-04	1998-05-04
PCT/US1998/013107 WO1998058641A1 (en)	1997-06-25	1998-06-24	Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases

Publications (2)

Publication Number	Publication Date
IS5239A true IS5239A (is)	1999-11-05
IS2279B IS2279B (is)	2007-09-15

Family

ID=26728613

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5239A IS2279B (is)	1997-06-25	1999-11-05	Notkun á hliðstæðum gamma-amínósmjörsýru (GABA) áborð við GABA-pentín til vinnslu lyfs til meðferðar á bólgusjúkdómum

Country Status (20)

Country	Link
EP (1)	EP0994704B1 (is)
JP (2)	JP3884486B2 (is)
KR (1)	KR100554319B1 (is)
AT (1)	ATE297722T1 (is)
AU (1)	AU735675B2 (is)
CA (1)	CA2294607C (is)
CO (1)	CO4940456A1 (is)
DE (1)	DE69830586T2 (is)
DK (1)	DK0994704T3 (is)
ES (1)	ES2244070T3 (is)
HR (1)	HRP980342A2 (is)
HU (1)	HU228454B1 (is)
IL (2)	IL132709A0 (is)
IS (1)	IS2279B (is)
NO (1)	NO329321B1 (is)
NZ (1)	NZ501626A (is)
PL (1)	PL191370B1 (is)
PT (1)	PT994704E (is)
SI (1)	SI0994704T1 (is)
WO (1)	WO1998058641A1 (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL189872B1 (pl)	1996-07-24	2005-10-31	Warner Lambert Co	Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
HUP0004310A3 (en)	1997-10-27	2001-11-28	Warner Lambert Co	Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
AU2463099A (en) *	1998-01-23	1999-08-09	Warner-Lambert Company	Gabapentin and its derivatives for the treatment of muscular and skeletal pain
EP0974351A3 (en) *	1998-04-24	2000-12-13	Jouveinal	Medicament for preventing and treating gastrointestinal damage
ES2287021T3 (es)	1999-07-22	2007-12-16	University Of Rochester	Metodo para el tratamiento de sintomas de variacines hormonales que incluyen el fogaje.
US6620829B2 (en) *	2000-10-17	2003-09-16	Warner-Lambert Company	Method of treating noninflammatory cartilage damage
CA2451267A1 (en) *	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
EP1543831A1 (en) *	2003-12-18	2005-06-22	Pfizer GmbH Arzneimittelwerk Gödecke	Pregabalin composition
WO2006008640A1 (en) *	2004-07-15	2006-01-26	Pharmacia & Upjohn Company Llc	Non-aqueous suspension containing a drug having an unpleasant taste
EP2240158A2 (en) *	2007-12-28	2010-10-20	Intas Pharmaceuticals Limited	Stabilized injectable formulation of pregabalin
HU230031B1 (hu)	2010-03-01	2015-05-28	Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság	Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
EP2575798B1 (en)	2010-06-01	2017-08-09	Rubicon Research Private Limited	Gastroretentive dosage forms of gaba analogs
TW201613625A (en) *	2014-08-29	2016-04-16	Wakamoto Pharma Co Ltd	Lactic acid bacteria-containing composition
GB201617380D0 (en)	2016-10-13	2016-11-30	St George's Hospital Medical School	Treatment for Osteoarthritis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2460891C2 (de) *	1974-12-21	1982-09-23	Gödecke AG, 1000 Berlin	1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
JPS6036413A (ja) *	1983-08-09	1985-02-25	Kaneshiro Nagai	炎症治癒促進剤
US6197819B1 (en) *	1990-11-27	2001-03-06	Northwestern University	Gamma amino butyric acid analogs and optical isomers
JPH0636413A (ja) *	1992-07-21	1994-02-10	Nakamichi Corp	テ−プレコ−ダのテ−プガイド装置
PL189872B1 (pl) *	1996-07-24	2005-10-31	Warner Lambert Co	Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
WO1998017627A1 (en) *	1996-10-23	1998-04-30	Warner-Lambert Company	Substituted gamma aminobutyric acids as pharmaceutical agents

1998
- 1998-06-19 HR HR60/084,183A patent/HRP980342A2/hr not_active Application Discontinuation
- 1998-06-24 CA CA002294607A patent/CA2294607C/en not_active Expired - Lifetime
- 1998-06-24 SI SI9830778T patent/SI0994704T1/xx unknown
- 1998-06-24 JP JP50502199A patent/JP3884486B2/ja not_active Expired - Lifetime
- 1998-06-24 DK DK98934170T patent/DK0994704T3/da active
- 1998-06-24 AT AT98934170T patent/ATE297722T1/de active
- 1998-06-24 NZ NZ501626A patent/NZ501626A/en not_active IP Right Cessation
- 1998-06-24 PL PL337847A patent/PL191370B1/pl unknown
- 1998-06-24 WO PCT/US1998/013107 patent/WO1998058641A1/en not_active Ceased
- 1998-06-24 EP EP98934170A patent/EP0994704B1/en not_active Expired - Lifetime
- 1998-06-24 HU HU0003730A patent/HU228454B1/hu unknown
- 1998-06-24 KR KR1019997012256A patent/KR100554319B1/ko not_active Expired - Lifetime
- 1998-06-24 DE DE69830586T patent/DE69830586T2/de not_active Expired - Lifetime
- 1998-06-24 IL IL13270998A patent/IL132709A0/xx active IP Right Grant
- 1998-06-24 PT PT98934170T patent/PT994704E/pt unknown
- 1998-06-24 CO CO98035766A patent/CO4940456A1/es unknown
- 1998-06-24 AU AU83758/98A patent/AU735675B2/en not_active Expired
- 1998-06-24 ES ES98934170T patent/ES2244070T3/es not_active Expired - Lifetime
1999
- 1999-11-02 IL IL132709A patent/IL132709A/en not_active IP Right Cessation
- 1999-11-05 IS IS5239A patent/IS2279B/is unknown
- 1999-12-23 NO NO19996468A patent/NO329321B1/no not_active IP Right Cessation
2006
- 2006-05-24 JP JP2006143571A patent/JP4452255B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
KR20010020509A (ko)	2001-03-15
CA2294607C (en)	2007-09-25
IS2279B (is)	2007-09-15
JP4452255B2 (ja)	2010-04-21
PL191370B1 (pl)	2006-05-31
ATE297722T1 (de)	2005-07-15
HU228454B1 (en)	2013-03-28
DE69830586T2 (de)	2005-12-15
EP0994704B1 (en)	2005-06-15
JP2002506449A (ja)	2002-02-26
HUP0003730A1 (hu)	2001-04-28
IL132709A0 (en)	2001-03-19
EP0994704A1 (en)	2000-04-26
PL337847A1 (en)	2000-09-11
JP3884486B2 (ja)	2007-02-21
JP2006298929A (ja)	2006-11-02
ES2244070T3 (es)	2005-12-01
NO996468D0 (no)	1999-12-23
CO4940456A1 (es)	2000-07-24
SI0994704T1 (en)	2005-10-31
KR100554319B1 (ko)	2006-02-22
NO996468L (no)	2000-02-21
PT994704E (pt)	2005-08-31
IL132709A (en)	2006-10-05
HRP980342A2 (en)	1999-02-28
AU8375898A (en)	1999-01-04
CA2294607A1 (en)	1998-12-30
NZ501626A (en)	2002-03-28
AU735675B2 (en)	2001-07-12
DK0994704T3 (da)	2005-10-03
HUP0003730A3 (en)	2002-01-28
WO1998058641A1 (en)	1998-12-30
DE69830586D1 (de)	2005-07-21
NO329321B1 (no)	2010-09-27

Publication	Publication Date	Title
ATE461698T1 (de)	2010-04-15	Gaba-analoga zur verhütung und behandlung gastrointestinaler beschwerden
IS5239A (is)	1999-11-05	Notkun á hliðstæðum gamma-amínósmjörsýru (GABA) áborð við GABA-pentín til vinnslu lyfs til meðferðar á bólgusjúkdómum
ES2159851T3 (es)	2001-10-16	Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
ID28485A (id)	2001-05-31	Proses yang terus berlangsung untuk pembuatan asam n-(fosfonometil) iminodiasetat
DE59509088D1 (de)	2001-04-19	Kombination von Nekrose-induzierenden Substanzen mit Substanzen, die durch Nekrosen aktiviert werden, zur selektiven Therapie von Tumoren und entzündlichen Erkrankungen
ATE35136T1 (de)	1988-07-15	Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
UY26474A1 (es)	2001-01-31	Inhibidores de aminotransferasa dependiente de aminoácidos de cadena ramificada, y su uso en el tratamiento de la retinopatía diabética.
DE69611598D1 (de)	2001-02-22	Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen
DK0842169T3 (da)	2001-01-29	Benzothiophenforbindelser
ATE290384T1 (de)	2005-03-15	Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
ES2182890T3 (es)	2003-03-16	Sintesis de acidos 4-arilo-2-hidroxitetronicos opticamente puros.
DE602004003173D1 (de)	2006-12-28	Verwendung von konjugierter Linolsäure zur Behandlung der Erkältung
NO20010116D0 (no)	2001-01-08	Farmasöytisk preparat inneholdende GABA-analoger og et antiviralt middel for å behandle helvetesild
BR9812265A (pt)	2000-07-18	Uso de análogos de gaba, tais como gabapentina, na fabricação de um medicamento para o tratamento de doenças inflamatórias.
DE69927591D1 (de)	2006-02-16	Behandlung von nierenkolik mit gaba-analogen
GT199900042A (es)	2000-09-14	Derivados biciclicos del acido hidroxamico.
UA34350A (uk)	2001-02-15	Спосіб комплексного лікування генералізованого пародонтиту
LT2002109A (en)	2004-04-26	Oinment for treatment of wounds and burnings